March 31, 2015

Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed. 

March 31, 2015

The drug is Food and Drug Administration-approved to treat opioid-induced constipation in adults with chronic, non-cancer pain. 

March 30, 2015

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

March 27, 2015

More than 350 pharmacy advocates headed to Capitol Hill for the seventh annual NACDS RxIMPACT Day to further reinforce the recognition by lawmakers of the evolving role of pharmacy in patient care and educate members of Congress about pro-patient, pro-pharmacy policy.

March 27, 2015

The Food and Drug Adminisration on Friday revisited the issue of supplemental applications proposing labeling changes for approved drugs and biologic products. 

March 24, 2015

Actavis last week announced that its acquisition of Allergan has been completed in a transaction valued at $70.5 billion, a deal that creates one of the world’s top 10 pharmaceutical companies by sales revenue, according to the company.

March 17, 2015

A new Harris Poll reveals some surprise findings on Americans' preference for generic or branded drugs.

March 16, 2015

Healthiest You on Monday launched a healthcare price comparison app that helps ascertain the cost of procedures and pharmaceuticals. 

March 16, 2015

Intradermal quadrivalent flu vaccine found to be more productive than trivalent vaccine, according to Saint Louis University research.

March 13, 2015

Actavis on Friday announced that the Food and Drug Administration approved Saphris for the treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients.

March 13, 2015

An Altarum report found that national health spending increased 5.7% in January 2015 vs. January 2014. 

March 11, 2015

A new MIT study published Wednesday suggests that a more powerful H1N1 influenza strain may be making its way through India. 

March 11, 2015

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.

March 10, 2015

Purdue Pharma's Stephen Seid honored with HDMA's 2015 Distribution Management Award for Industry Leadership. 

 

March 10, 2015

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.

March 9, 2015

Apple on Monday better enabled medical research with the launch of open source software framework ResearchKit. 

March 6, 2015

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

February 27, 2015

ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.

February 27, 2015

GlaxoSmithKline expects to complete its Novartis transaction in the week commencing March 2.

February 27, 2015

Nine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends. 

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 26, 2015

Protein Sciences expanded Flublok distribution through Cardinal, McKesson this week.